Business
CHF P3 Trial Accrues Sufficient Primary Endpoint Events
CHF P3 Trial Accrues Sufficient Primary Endpoint Events
About this update from Mesoblast Limited
[{"type":"text","content":"Mesoblast Ltd has released a press release. View Attachment","length":226,"tagName":"div"}]